Fred Hutch Shows Success with CAR T Cell Immunotherapy

In a recent interview with KIRO 7, Gary Gilliard, president of Fred Hutchinson Cancer Research Center in Seattle, talked about the success they are having with CAR T cell immunotherapies for some metastatic cancers. The Hutch has long been a leader in immunotherapy research and has made many lifesaving discoveries harnessing the power of the…

Read more

Factors Impacting DMARD Adherence in RA Patients

With well over one million Americans living with Rheumatoid Arthritis, there has been an interest in developing antirheumatic treatments dating back to the 1930s, giving rise to the classification of “disease-modifying antirheumatic drugs” (DMARDs) in the 1970s and 1980s. Of course, any drug or therapy will be most effective when patients adhere to the prescribed…

Read more

5 Reasons to Buy Normal PBMC

Human peripheral blood mononuclear cells (PBMC) are one of our most popular products among researchers in academia, pharma and biotech. Here are five reasons to buy PBMC from normal, healthy donors from us:   1. 50+ Donors Available We source our PBMC from a variety of donors to give you the best selection. With more…

Read more

10 Reasons to Outsource Immunology Research Services

Outsourcing research services is a popular practice among pharma and biotech companies of all sizes. For enterprise pharma companies, emerging biotechs, and everyone in between, there is tremendous value in contracting labs to run your research projects. Learn ten reasons why the outsource research services model may be the right choice for your company. If…

Read more

The Rise of Specialty Drugs and the Impact on Market Growth

Specialty drugs — often described as “prescription drugs that are difficult to manufacture and require special handling or administration, have limited distribution, target a narrow group of chronic diseases, are costly, and require ongoing clinical support — will drive nearly all of the pharmaceutical industry’s market growth from 2015–2020. Drug Channels projects the total pharmaceutical…

Read more

3 Benefits of Mouse T Regulatory Cells for Research

We wrote a post back in November 2016 comparing natural human T regulatory cells and induced human T regulatory cells. While both have unique benefits and are great options for studying the immune system, you also have a third option for Tregs: mouse T regulatory cells. You may not think of mouse Tregs for immune-oncology…

Read more

Announcing a New List of SLE Donors

We are happy to announce the availability of an expanded list of SLE donors in our immune cell catalog. In partnership with Physicians Plasma Alliance, we have isolated PBMC, purified CD4+ T cells, and purified CD8+ T cells from donors with SLE (Systemic Lupus Erythematosis). Although Physicians Plasma Alliance is located in Tennessee, we are…

Read more